Ocumetics Director and CEO, Dean Burns covers important updates on our first-in-human (FIH) study and what lies ahead. Topics include: Encouraging outcomes from initial surgeries Next steps to complete the FIH study Live Q&A session with Dean Burns https://youtu.be/rWQnOaq6sVE

This past week, we reached a milestone that is nothing short of extraordinary. Our very first patients received the Ocumetics Accommodating Intraocular Lens. Just one week later, they are recovering well—and importantly, no complications have been observed. I cannot overstate how meaningful this moment is. For years, we have poured our hearts, energy, and belief

Today, Ocumetics has entered the history books. Nearly two decades of relentless innovation, bold ambition, and unwavering belief have led to this defining moment: the first-in-human implantation of the Ocumetics Lens. What many once thought impossible is now reality. This achievement is not the work of one person or one idea, but the result of

Ocumetics Director and CEO, Dean Burns, covers key details of our upcoming first-in-human study and recently opened private placement financing. Topics will include: Final steps leading up to the first-in-human study Details on the now-open private placement investment opportunity Live Q&A session with Dean Burns Thanks to everyone who joined us for the Webinar. It